European Meeting on HIV & Hepatitis

Dear Colleague,

We are pleased to announce the 15th edition of the European Meeting on HIV & Hepatitis - Treatment Strategies & Anviral Drug Resistance,  to be held 7 - 9 June 2017 at the Roma Eventi - Fontana di Trevi Conference Centre in Rome, Italy.


"The premier European platform for clinicians and clinical virologists to discuss the latest developments in antiviral therapy for HIV, HCV and HBV and for translating them into new treatment strategies to further improve clinical care. "


Rome935532_12435801The European HIV and Hepatitis meeting was started 15 years ago with the objective to provide infectious disease clinicians and clinical virologists involved in antiviral clinical practice and research with an opportunity to share data and discuss their clinical application. Over the years the challenges facing European clinicians treating HIV patients expanded. As resistance was better understood and managed, broader treatment issues (adherence, toxicity, etc.) were added to the workshop. Similarly, as better treatment options for HCV became available, many of them were required to treat viral Hepatitis as well. Therefore the workshop (and its name) was expanded to keep pace with the needs of the European clinicians – The European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance. Although resistance is still an important feature of the meeting, other key topics in treatment strategies are addressed similarly. Whereas HIV remains very much a key component, treatment of Hepatitis infection is also included.

In the last decade the meeting has been able to capture a constant group of leading clinicians and researchers from Europe. As such, this meeting is the only European platform where infectious disease doctors and clinical virologists get together on an annual basis to present their latest research results and discuss the clinical implications in detail.

By attending the 15th edition of this meeting, you will receive a full overview of the latest developments in Hepatitis B, C and HIV, translated to clinical practice. The meeting will provide ample time for Q & A, discussion and interaction in a balanced and neutral scientific environment. Furthermore, much attention will be given to clinical management through extensive clinical case discussions.

We look forward to seeing you in Rome!

A short impression of the 2016-edition: